Investigative Urology - Results from #6220

An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice - Abstract April 6, 2012

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells - Abstract April 6, 2012

PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells - Abstract April 6, 2012

Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes - Abstract April 6, 2012

Is there an additional value of (11)C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? - Abstract April 6, 2012

PTP1B Is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer - Abstract April 6, 2012

Critical role of O-GlcNAc transferase in prostate cancer invasion, angiogenesis and metastasis - Abstract April 5, 2012

A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease - Abstract April 5, 2012

Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells - Abstract April 5, 2012

Antiproliferative effects of Dangyuja (Citrus grandis Osbeck) leaves through suppression of constitutive signal transducer and activator of transcription 3 activation in human prostate carcinoma DU145 cells - Abstract April 5, 2012

Utility of Genome-Wide Association study findings: Prostate cancer as a translational research paradigm - Abstract April 5, 2012

The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells - Abstract April 4, 2012

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer - Abstract April 4, 2012

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry - Abstract April 4, 2012

Regulation of TGF-β1 expression by Androgen Deprivation Therapy of prostate cancer - Abstract April 4, 2012

Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 - Abstract April 4, 2012

Proliferative effect of whey from cows' milk varying in phyto-oestrogens in human breast and prostate cancer cells - Abstract April 4, 2012

Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment - Abstract April 3, 2012

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression - Abstract April 3, 2012

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer - Abstract April 3, 2012

Page 312 of 346